BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33294267)

  • 1. Shikonin enhances the antitumor effect of cabazitaxel in prostate cancer stem cells and reverses cabazitaxel resistance by inhibiting ABCG2 and ALDH3A1.
    Wang L; Stadlbauer B; Lyu C; Buchner A; Pohla H
    Am J Cancer Res; 2020; 10(11):3784-3800. PubMed ID: 33294267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berbamine targets cancer stem cells and reverses cabazitaxel resistance via inhibiting IGF2BP1 and p-STAT3 in prostate cancer.
    Wang L; Lyu C; Stadlbauer B; Buchner A; Nößner E; Pohla H
    Prostate; 2024 Feb; 84(2):131-147. PubMed ID: 37828768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment of prostate cancer cells with salinomycin and Wnt inhibitor increases the efficacy of cabazitaxel by inducing apoptosis and decreasing cancer stem cells.
    Serttas R; Erdogan S
    Med Oncol; 2023 Jun; 40(7):194. PubMed ID: 37264204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fisetin Enhances Chemotherapeutic Effect of Cabazitaxel against Human Prostate Cancer Cells.
    Mukhtar E; Adhami VM; Siddiqui IA; Verma AK; Mukhtar H
    Mol Cancer Ther; 2016 Dec; 15(12):2863-2874. PubMed ID: 27765854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberis libanotica Ehrenb extract shows anti-neoplastic effects on prostate cancer stem/progenitor cells.
    El-Merahbi R; Liu YN; Eid A; Daoud G; Hosry L; Monzer A; Mouhieddine TH; Hamade A; Najjar F; Abou-Kheir W
    PLoS One; 2014; 9(11):e112453. PubMed ID: 25380390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
    Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
    Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive oxygen species induction by cabazitaxel through inhibiting Sestrin-3 in castration resistant prostate cancer.
    Kosaka T; Hongo H; Miyazaki Y; Nishimoto K; Miyajima A; Oya M
    Oncotarget; 2017 Oct; 8(50):87675-87683. PubMed ID: 29152111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells.
    Natsagdorj A; Izumi K; Hiratsuka K; Machioka K; Iwamoto H; Naito R; Makino T; Kadomoto S; Shigehara K; Kadono Y; Lin WJ; Maolake A; Mizokami A
    Cancer Sci; 2019 Jan; 110(1):279-288. PubMed ID: 30426599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells.
    Jagust P; Alcalá S; Sainz Jr B; Heeschen C; Sancho P
    World J Stem Cells; 2020 Nov; 12(11):1410-1428. PubMed ID: 33312407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zoledronic acid overcomes chemoresistance by sensitizing cancer stem cells to apoptosis.
    Rouhrazi H; Turgan N; Oktem G
    Biotech Histochem; 2018; 93(2):77-88. PubMed ID: 29300112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shikonin selectively induces apoptosis in human prostate cancer cells through the endoplasmic reticulum stress and mitochondrial apoptotic pathway.
    Gara RK; Srivastava VK; Duggal S; Bagga JK; Bhatt M; Sanyal S; Mishra DP
    J Biomed Sci; 2015 Apr; 22(1):26. PubMed ID: 25879420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway.
    Li X; Fan XX; Jiang ZB; Loo WT; Yao XJ; Leung EL; Chow LW; Liu L
    Pharmacol Res; 2017 Jan; 115():45-55. PubMed ID: 27864022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isobutyrylshikonin has a potentially stronger cytotoxic effect in oral cancer cells than its analogue shikonin in vitro.
    Park DG; Kim DJ; Woo BH; Kim HJ; Choi YW; Park HR
    Arch Oral Biol; 2020 Aug; 116():104774. PubMed ID: 32470830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cabazitaxel regimens inhibit the growth of prostate cancer cells and enhances the anti-tumor properties of PEDF with various efficacy and toxicity.
    Jarvis C; Nelius T; Martinez-Marin D; Sennoune SR; Filleur S
    Prostate; 2018 Sep; 78(12):905-914. PubMed ID: 29749077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-regulated protein 78 mediates the anticancer efficacy of shikonin in hormone-refractory prostate cancer cells.
    Kuo LJ; Huang CY; Cheng WL; Hung CS; Wu CT; Lin FY; Chang YJ; Huang MT
    Tumour Biol; 2015 Jul; 36(7):5063-70. PubMed ID: 25669168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metformin inhibits self-renewal of colorectal cancer stem cells by inhibiting mitochondrial oxidative phosphorylation].
    Yan C; Liu S; Song Q; Hu Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Aug; 43(8):1279-1286. PubMed ID: 37712263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxycycline Induces Apoptosis and Inhibits Proliferation and Invasion of Human Cervical Carcinoma Stem Cells.
    Yang B; Lu Y; Zhang A; Zhou A; Zhang L; Zhang L; Gao L; Zang Y; Tang X; Sun L
    PLoS One; 2015; 10(6):e0129138. PubMed ID: 26111245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shikonin Promotes Apoptosis and Attenuates Migration and Invasion of Human Esophageal Cancer Cells by Inhibiting Tumor Necrosis Factor Receptor-Associated Protein 1 Expression and AKT/mTOR Signaling Pathway.
    Huang J; Zhao L; Gong C; Wang Y; Qu Y; Ji C; Yang J
    Evid Based Complement Alternat Med; 2021; 2021():5386050. PubMed ID: 34812264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinacrine and curcumin synergistically increased the breast cancer stem cells death by inhibiting ABCG2 and modulating DNA damage repair pathway.
    Nayak D; Tripathi N; Kathuria D; Siddharth S; Nayak A; Bharatam PV; Kundu C
    Int J Biochem Cell Biol; 2020 Feb; 119():105682. PubMed ID: 31877386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Apoptotic Activity Against Prostate Cancer Stem Cells.
    Jaworska D; Szliszka E
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.